Wells Fargo & Company Issues Pessimistic Forecast for Autolus Therapeutics (NASDAQ:AUTL) Stock Price
Autolus Therapeutics (NASDAQ:AUTL – Free Report) had its price objective reduced by Wells Fargo & Company from $8.00 to $6.00 in a research report report published on Friday,Benzinga reports. They currently have an overweight rating on the stock. Separately, Needham & Company LLC reissued a “buy” rating and set a $10.00 price objective on shares […]
Autolus Therapeutics (NASDAQ:AUTL – Free Report) had its price objective reduced by Wells Fargo & Company from $8.00 to $6.00 in a research report report published on Friday,Benzinga reports. They currently have an overweight rating on the stock. Separately, Needham & Company LLC reissued a “buy” rating and set a $10.00 price objective on shares […]
